NCT03844048 2026-03-06
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
AbbVie
Phase 3 Active not recruiting
AbbVie
Case Comprehensive Cancer Center
Eli Lilly and Company
Case Comprehensive Cancer Center